Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in US

May 26, 2020

The first human clinical trials for Pfizer’s and BioNTech’s experimental COVID-19 vaccine, BNT162, have begun in the U.S. The vaccine is undergoing an accelerated trial process that Pfizer’s CEO Albert Bourla called “extraordinary.”

Four different versions of the vaccine, which uses messenger RNA (mRNA), will be administered to the volunteer subjects. According to researchers at University of Pennsylvania and Duke University, mRNA vaccines have potential safety issues, including local and systemic inflammation and stimulation of auto-reactive antibodies and autoimmunity, as well as development of edema (swelling) and blood clots.

SOURCE: The Vaccine Reaction May 25, 2020

Revolutionary Forum: Transforming Your Health Information Experience

Exciting news! We're thrilled to announce the development of a cutting-edge forum that will revolutionize how you engage with health information online. This major upgrade to our content management system will provide you with one of the best-in-class forums on the internet, designed to exceed all current offerings and transform your experience.

Our new forum will feature a dedicated health community section, allowing for more meaningful interactions and ensuring your questions are properly addressed—a significant improvement over our previous model. While we understand that the temporary removal of comments may be disappointing, we assure you that this change paves the way for a far superior platform.

This transformative project is on track for a future launch. We appreciate your patience as we work diligently to bring you this groundbreaking resource. In the meantime, we're committed to dramatically enhancing our free content offerings, giving you even more valuable health information at your fingertips.

Expanding Our Reach to Elite Levels

The release of my innovative book, " Your Guide to Cellular Health: Unlocking the Science of Longevity and Joy," coupled with the groundbreaking technical advancements of the upcoming Mercola Health Coach, is expected to skyrocket our site traffic. We anticipate becoming the most visited health sites globally, far surpassing our current traffic.

This remarkable growth would place us among the most visited websites globally. Looking ahead, we're setting our sights even higher, with the ambitious goal of eventually breaking into the top most visited sites worldwide. This vision reflects our commitment to making reliable, cutting-edge health information accessible to an ever-growing global audience.

The Future of Health Education: Our Vision for 2025 and Beyond

For decades, we've been privileged to help hundreds of millions with their health journey. Now, we're aiming higher. This forum upgrade marks one of our important major steps towards that goal, promising to usher in a new era of health education and community support. Stay tuned for updates as we work tirelessly to bring you this game-changing platform!